J4 ›› 2012, Vol. 38 ›› Issue (6): 1073-1076.

• 基础研究 • 上一篇    下一篇

红景天苷与骨髓间充质干细胞联合应用对帕金森病大鼠的治疗作用

范东艳1|王苹2|陈玉丙3   

  1. (1.西藏大学医学院预防医学系|西藏 拉萨 850000;2.吉林大学第一医院耳鼻咽喉-头颈外科|吉林 长春130021;3.吉林大学第二医院核医学科|吉林 长春 130041)
  • 收稿日期:2012-05-23 出版日期:2012-11-28 发布日期:2012-11-28
  • 通讯作者: 陈玉丙 E-mail:(Tel:0431-88796179,E-mail: yb0707@163.com)
  • 作者简介:范东艳(1973-)|女|吉林省吉林市人|讲师|医学博士|主要从事干细胞应用研究。
  • 基金资助:

    国家自然科学基金资助课题(81160360);西藏大学科研启动经费资助课题(2010-2013)

Treatment effect of salidroside combined with bone marrow mesenchymal stem cells on rats with Parkinson’s disease

FAN Dong-yan1,WANG Ping2,CHEN Yu-bing3   

  1. (1.Department of Preventive Medicine,Medical School,Tibet University,Lhasa 850000,China|2.Department |of Otorhinolaryngology and Head-Neck Surgery,First Hospital,Jilin University,Chan
    gchun 130021,China|3. Depatment of Nuclear Medicine,Second Hospital,J ilin University,Changchun 130041,China)
  • Received:2012-05-23 Online:2012-11-28 Published:2012-11-28

摘要:

目的:研究红景天苷与骨髓间充质干细胞(BMSCs)联合应用对帕金森病(PD)大鼠的治疗作用,为PD治疗提供实验基础。方法:采用贴壁法培养BMSCs,免疫荧光法检测细胞表面分子。利用MTT法分析10 mg·L-1红景天苷对BMSCs增殖分化的影响。将60只大鼠随机分为假手术组、模型组、红景天苷治疗组、BMSCs治疗组、红景天苷和BMSCs联合治疗组,每组12只。在相对应的时间点检测各组大鼠行为学变化,取各组大鼠脑组织测定酪氨酸羟化酶(TH) mRNA表达水平。结果:成功分离提取表达干细胞标志物CD29和CD44细胞。 红景天苷作用BMSCs后,BMSCs增殖较对照组更为旺盛且平台期较对照组延长。PD模型组大鼠旋转次数减少,与其他组比较差异有统计学意义(P<0.05);模型组大鼠行为改变明显,脑组织内TH mRNA表达水平降低。红景天苷和BMSCs联合治疗组大鼠行为学异常程度较轻,脑组织内TH mRNA表达水平高于其他组(P<0.05)。结论:红景天苷与BMSCs联合应用对PD大鼠的治疗作用优于单独应用红景天苷或BMSCs。

关键词: 红景天苷; 骨髓间充质干细胞; 帕金森病

Abstract:

 To study the treatment effect of salidroside combined with bone marrow mesenchymal stem cells (BMSCs) on rats with Parkinson’s disease(PD),and to provide experiment basis for curring Parkinson’s disease.Methods The BMSCs were cultured adherently,the cell surface molecules were detected by immunofluorescence.The effect of 10 mg·L-1 salidroside on the proliferation and differentiation of BMSCs was detected by MTT.60  Wistar rats were randomly divided into sham group,model group,salidroside treatment group,BMSCs treatment group,and  salidroside and BMSCs combination therapy group.The behavior changes were detected at a specific time  and  the levels of tyrosin hydroxylase(TH) mRNA in brain tissue were detected.Results The setm cell markers CD29 and CD44 were expressed  successfully.Compared with control group,the proliferation of BMSCs got bigger and the plateau got longer after treated with salidroside.The rotation number of PD model rats was the least compared with the other groups(P<0.05).The expression level of TH mRNA wasdecreased.The behavior abnormalities of PD model rats were improved and the level of TH mRNA was increased  after treated with salidroside and  BMSCs compared with the other groups(P<0.05).Conclusion The treatment efficacy of salidroside combined with BMSCs on PD rats is better than salidroside or BMSCs alone.

Key words: salidroside, bone mesenchymal stem cells, Parkinson’s disease

中图分类号: 

  • R745